Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dipeptidyl-Peptidase 4 Inhibitors”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01106677
What this trial is testing

The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 1,284
Large-scale testing (Phase 3)Not Yet RecruitingNCT07241897
What this trial is testing

DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes

Who this might be right for
Ischemic StrokeDiabete Mellitus
Second Affiliated Hospital of Soochow University 312
Early research (Phase 1)Study completedNCT00551590
What this trial is testing

Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Ludwig-Maximilians - University of Munich 24
Large-scale testing (Phase 3)Study completedNCT00968708
What this trial is testing

Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Who this might be right for
Diabetes Mellitus, Type 2Acute Coronary Syndrome
Takeda 5,380
Not applicableUnknownNCT06570980
What this trial is testing

Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM), Cost-effectiveness, Sulfonylureas, DPP4 Inhibitors, Metformin
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 200
Post-approval studies (Phase 4)Study completedNCT02941445
What this trial is testing

Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

Who this might be right for
Polycystic Ovary SyndromeBody Weight
University Medical Centre Ljubljana 24
Large-scale testing (Phase 3)Study completedNCT00614939
What this trial is testing

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Who this might be right for
Type 2 Diabetes
AstraZeneca 572
Post-approval studies (Phase 4)WithdrawnNCT02263677
What this trial is testing

Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI

Who this might be right for
Type 2 DiabetesNon-alcoholic Fatty Liver Disease
University of Missouri-Columbia
Not applicableEnded earlyNCT02244164
What this trial is testing

Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

Who this might be right for
Type 2 DiabetesIncretinomimeticsPancreas
Erasme University Hospital 5
Large-scale testing (Phase 3)Study completedNCT01922817
What this trial is testing

DPP4inhibitors in Type 1 Diabetes

Who this might be right for
Type 1 DiabetesHypoglycaemia
University of Dundee 28
Large-scale testing (Phase 3)Study completedNCT02377388
What this trial is testing

DPP-4 Inhibitors and Acute Myocardial Infarction:Effects on Platelet Function

Who this might be right for
Platelet Aggregation During Acute Myocardial Infarction
University of Sao Paulo General Hospital 74
Large-scale testing (Phase 3)Study completedNCT04218734
What this trial is testing

DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM

Who this might be right for
Type 2 Diabetes Mellitus
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 214
Early research (Phase 1)Study completedNCT02009488
What this trial is testing

Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 59
Testing effectiveness (Phase 2)Study completedNCT06703268
What this trial is testing

A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Haisco Pharmaceutical Group Co., Ltd. 64
Post-approval studies (Phase 4)Study completedNCT02639637
What this trial is testing

Effect of DPP4 Inhibition on Vasoconstriction

Who this might be right for
Type 2 Diabetes Mellitus
Vanderbilt University 18
Large-scale testing (Phase 3)Enrolling By InvitationNCT07073768
What this trial is testing

Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients

Who this might be right for
Diabetes Mellitus Type 2Glycemic Control for Diabetes Mellitus
Khyber Medical College, Peshawar 126
Not applicableStudy completedNCT02792400
What this trial is testing

The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors

Who this might be right for
Type 2 Diabetes
University Hospital, Gentofte, Copenhagen 24
Early research (Phase 1)Study completedNCT00813228
What this trial is testing

Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals

Who this might be right for
Diabetes Mellitus Type 1Diabetes Mellitus Type 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 76
Large-scale testing (Phase 3)Study completedNCT03351478
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 770
Large-scale testing (Phase 3)Study completedNCT01798238
What this trial is testing

Teneligliptin(MP-513) Versus Placebo in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Handok Inc. 142
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation